ASTH
Astrana Health Inc.

491
Mkt Cap
$1.56B
Volume
308,658.00
52W High
$60.99
52W Low
$21.20
PE Ratio
60.46
ASTH Fundamentals
Price
$31.21
Prev Close
$31.81
Open
$31.37
50D MA
$30.34
Beta
0.91
Avg. Volume
366,654.57
EPS (Annual)
$0.8994
P/B
2.00
Rev/Employee
$1.07M
Loading...
Loading...
News
all
press releases
DaVita HealthCare (DVA) Q3 Earnings Lag Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of -23.71% and +0.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
More News
News Placeholder
Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call
Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call PR...
PR Newswire·17d ago
News Placeholder
ASTH vs. USPH: Which Stock Is the Better Value Option?
ASTH vs. USPH: Which Stock Is the Better Value Option?
Zacks·2mo ago
News Placeholder
Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
Zacks·2mo ago
News Placeholder
ASTH or USPH: Which Is the Better Value Stock Right Now?
ASTH vs. USPH: Which Stock Is the Better Value Option?
Zacks·3mo ago
News Placeholder
Zacks.com featured highlights include Astrana Health, BJ's Restaurants, KT Corporation and Global Ship Lease
Astrana Health, BJ's Restaurants, KT Corporation, and Global Ship Lease shine with low EV-to-EBITDA ratios and strong earnings growth outlooks.
Zacks·3mo ago
News Placeholder
Pick These 5 Bargain Stocks With Impressive EV-to-EBITDA Ratios
ASTH, BJRI, ADT, KT and GSL stand out with low EV-to-EBITDA ratios and strong earnings growth forecasts.
Zacks·3mo ago
News Placeholder
Astrana Health, Inc. (ASTH) Q2 Earnings Lag Estimates
Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of -47.22% and +2.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks
Value investors can consider buying high earnings yield stocks like B, ASTH, STNE, PHIN and PAGP for handsome returns.
Zacks·3mo ago
News Placeholder
ASTH vs. CHE: Which Stock Is the Better Value Option?
ASTH vs. CHE: Which Stock Is the Better Value Option?
Zacks·3mo ago

Latest ASTH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.